A Vaccine Strategy that Induces Protective Immunity against Heroin
- 21 June 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 54 (14), 5195-5204
- https://doi.org/10.1021/jm200461m
Abstract
Heroin addiction is a wide-reaching problem with a spectrum of damaging social consequences. A vaccine capable of blocking heroin’s effects could provide a long-lasting and sustainable adjunct to heroin addiction therapy. Heroin, however, presents a particularly challenging immunotherapeutic target, as it is metabolized to multiple psychoactive molecules. To reconcile this dilemma, we examined the idea of a singular vaccine with the potential to display multiple drug-like antigens; thus two haptens were synthesized, one heroin-like and another morphine-like in chemical structure. A key feature in this approach is that immunopresentation with the heroin-like hapten is thought to be immunochemically dynamic such that multiple haptens are simultaneously presented to the immune system. We demonstrate the significance of this approach through the extremely rapid generation of robust polyclonal antibody titers with remarkable specificity. Importantly, both the antinociceptive effects of heroin and acquisition of heroin self-administration were blocked in rats vaccinated using the heroin-like hapten.Keywords
This publication has 36 references indexed in Scilit:
- Escalation patterns of varying periods of heroin accessPharmacology Biochemistry and Behavior, 2011
- Impact of Distinct Chemical Structures for the Development of a Methamphetamine VaccineJournal of the American Chemical Society, 2011
- Unmasking the tonic-aversive state in neuropathic painNature Neuroscience, 2009
- Towards an understanding of the adjuvant action of aluminiumNature Reviews Immunology, 2009
- Population Pharmacokinetics of Heroin and its Major MetabolitesClinical Pharmacokinetics, 2006
- Nα-Fmoc Removal from Resin-Bound Amino Acids by 5% Piperidine SolutionJournal of Combinatorial Chemistry, 2004
- Morphine Modulates NFκB Activation in MacrophagesBiochemical and Biophysical Research Communications, 1998
- Is AIDS a disease of poverty?AIDS Care, 1996
- Species difference of site-selective glucuronidation of morphine.Journal of Pharmacobio-Dynamics, 1991
- DNA-Binding Compounds. III. Synthesis of a Peptide-Linked Binuclear Platinum(II)-Terpyridine ComplexAustralian Journal of Chemistry, 1990